Associate Director, DEICT Process LeadJanssen Research & Development LLC.Miami, United States
Disclosure information not submitted.
An evaluation of race and ethnicity-based representation among participants in phase III clinical trials for multiple myeloma
Wednesday, August 28, 20249:30 AM – 9:45 AM CEST